WHITEHAWK CAPITAL PARTNERS: PROVIDES $350 MILLION ASSET-BASED CREDIT FACILITY TO NEPHRON PHARMACEUTICALS
Source text: ID:nBw5qfFdna
(((( Reuters.Briefs@thomsonreuters.com ;));))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.